The OrthoK Knowledge Bank, is the complete source eye care professionals need to manage patients’ myopia using orthokeratology. The OrthoK Knowledge Bank includes information about everything ECPs require to successfully treat patients using corneal reshaping orthokeratology. Brought to you by...
Review of Myopia Management has released OrthoK 22: The Orthokeratology Education Initiative, OrthoK: The Complete Guide to Orthokeratology Success in Myopia Control covers everything from the history of OrthoK through the materials to successful fitting and patient management. In it,...
May 1, 2020 By Krupa Philip, B. Optom, PhD, and Padmaja Sankaridurg, B.Opt, MIP, PhD Brien Holden Vision Institute Optical strategies such...
May 1, 2020 By Jack L. Schaeffer, OD, FAAO In my optometric career, I have always believed in differentiating my practice by...
May 1, 2020 By Laura Kirkeby, CO The use of atropine has been known to slow the progression of myopia for many...
April 21, 2020 By Joe Rappon, OD, MS, FAAO Jay Neitz, PhD Maureen Neitz, PhD Spectacles have been the mainstay modality for...
AL measurement has not traditionally been considered part of mainstream optometry.
April 6, 2020 By Joshua Foreman, PhD Mohamed Dirani, PhD, MBA, GAICD Thanveer Ali, BSocSci (Hons) The COVID-19 pandemic continues to create...
April 1, 2020 By Xiangui He, MD, PhD Myopia, characterized by onset and rapid progression in childhood, is already a global health...
There are two strategies to consider for stopping atropine treatment.
March 1, 2020 By Dwight Akerman, OD, MBA, FAAO Chief Medical Editor, Review of Myopia Management To assess the effects of interventions...
>>Click HERE to explore the Ortho-K Knowledge Bank to learn how to make Ortho-K a success for both your patients and...
>>Click HERE to explore the Ortho-K Knowledge Bank to learn how to make Ortho-K a success for both your patients and...
Feb. 4, 2020 By Padmaja Sankaridurg, B.Opt, MIP, PhD Brien Holden Vision Institute The evidence for the rising prevalence of myopia and,...
Individual interventions may not result in the expected efficacy.
By Weizhong Lan, MD, PhD Dec. 3, 2019 It is well understood that myopia commonly onsets in early childhood and continues to...
Sponsored content By Matthew Martin, OD, FIAOMC In our practice, we specialize in Ortho-K, and two aspects are critical to our success:...
This summary of an International Myopia Institute (IMI) white paper was created by and is used with permission from the Centre for...
Troubleshooting in Ortho-K is best done when all of the crucial decision-making information is obtained for every visit.
Results of a recent study on combining orthokeratology and topical atropine 0.01%.
Good patient selection is paramount.
Results of a single masked, randomized two-year controlled clinical trial
The real value of this study, however, lies in the follow-up findings after cessation of the outdoor intervention.
Practitioners offering myopia management need to know the effect a patient’s binocular vision status has on their management strategies.
Presently, only atropine, pirenzepine, and 7-methylxanthine are shown to reduce myopia progression in human trials.
The researchers concluded that topical low-dose atropine appears to be safe and effective in a cohort of European schoolchildren.
Combined interventions for myopia will potentially influence the standard of care.
Existing evidence has failed to convince doctors to uniformly embrace treatments for myopic progression control.
Axial elongation rate is faster in younger children undergoing ortho-k treatment.